|Publication number||USRE39664 E1|
|Application number||US 08/561,215|
|Publication date||May 29, 2007|
|Filing date||Nov 21, 1995|
|Priority date||Sep 11, 1987|
|Also published as||US4956302|
|Publication number||08561215, 561215, US RE39664 E1, US RE39664E1, US-E1-RE39664, USRE39664 E1, USRE39664E1|
|Inventors||Julian Gordon, Charles Stuart Gredell Pugh|
|Original Assignee||Inverness Medical Switzerland Gmbh|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (34), Referenced by (29), Classifications (26)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation of application Ser. No. 08/322,027, filed Oct. 12, 1994 which is a continuation of application Ser. No. 07/942,493, filed Sep. 9, 1992.
The present invention relates generally to methods and devices for carrying out specific binding assays. More specifically, the invention relates to methods for the use of chromatographic transport for the movement of reagents and reactive sample components.
The use of specific binding assays has been found to be of great value in a variety of clinical and other applications. Such assays involve the detection and determination of an analyte substance which is a member of a specific binding pair consisting of a ligand and a receptor. The ligand and the receptor are related in that the receptor specifically binds to the ligands, being capable of distinguishing the ligand from other sample constituents having similar characteristics. Specific binding assays include immunological assays involving reactions between antibodies and antigens, DNA and RNA hybridization reactions and other specific binding reactions such as those involving hormone and other biological receptors. Specifically binding assays may be practiced according to a variety of formats well known in the art. Such assays include competitive binding assays, “direct” and “indirect” sandwich assays and agglutination assays.
Because the results of specific binding reactions are generally not directly observable, various techniques have been devised for labelling one member of the specific binding pair in order that the binding reaction may be indirectly observed. Useful labels include radiolabels, chromophores and fluorophores the presence of which may be detected by means of radiation detectors, spectrophotometers or the naked eye. Where members of a specific binding pair are tagged with an enzyme label, their presence may be detected by the enzymatic activation of a reaction system including a signal generating substrate/cofactor group wherein a compound such as a dyestuff, is activated to produce a detectable signal.
Specific binding assay devices are known in the art comprising vertically arranged elements including (a) a porous capture material which is impregnated at a reaction site with member of a specific binding pair such as an antibody or an antigen; (b) a removable prefilter disposed above the capture material and (c) a blotter disposed below the capture material. A sample liquid such as blood, serum or other biological fluid is added to the device wherein the prefilter removes particulates and other impurities from the sample which would otherwise be trapped on top of the specific binding capture material. Analyte substances within the sample are trapped by means of specific binding reactions with their specific binding partners on the capture material. Non-analyte components of the sample solution pass through the capture material and are absorbed by the blotter. Wash steps may be carried out to remove non-analyte components from the capture material and additional reagents such as enzyme substrates, cofactors and dye precursors, may be added to the capture material in order to indicate the presence or absence of analyte at the reaction site. The prefilter must then be removed in order that the presence or absence of analyte at the reaction site may be virtually determined. Such assay devices are rapid and generally reliable but suffer from limitations in capture efficiency and sensitivity because most of the analyte in the sampling material flows around rather than through the reaction site on the capture material.
Various disclosures are of interest to the present application. Tom, et al., U.S. Pat. No.4,366,241 discloses an immunoassay device comprising a relatively small test zone including a specific binding reagent, and a relatively large absorbing zone in liquid receiving relationship with said immunosorbing zone. Immunoassays for determining the presence of an analyte material are carried out by contacting the assay device with a sample solution, a solution containing enzyme labelled specific binding material and a solution containing an enzyme catalyzed signal system. The solutions migrate through the immunosorbing zone into the liquid absorbing zone and the presence of analyte in the sample material is indicated by enzyme activation of the signal system.
Deutsch, et al., U.S. Pat. Nos. 4,094,647, 4,235,601 and 4,361,537 relate to immunological and other types of specific binding assays wherein reagents are transported by chromatographic solvent transport. According to one embodiment, a radiolabeled competitive binding assay kit comprises a strip capable of transporting a developing liquid by capillarity having a first zone for receiving a sample, a second zone impregnated with a first reagent capable of being transported by the developing liquid and a third zone impregnated with a second reagent. In addition, the devices comprise a measuring zone and a retarding element which may be either the second reagent or the material of the strip. The first reagent is capable of reacting with one of the group consisting of (1) the sample, (2) the sample and the second reagent, and (3) the second reagent in competition with the sample, to form a product in an amount dependent on the characteristic being determined. A sample is contacted with the first zone and the strip is then dipped into the developing liquid to bring about transport of the sample and the first reagent to form the reaction product. The retarding element shows transport of either the product or the first reagent (the moving reagent) to spacially separate the two and the amount of the moving element is then measured at the measurement location.
Also of interest to the present invention is the disclosure of co-owned and copending U.S. patent application Ser. No. 912,878 filed Sept. 29, 1986 by Gordon, et al. U.S. Pat. No. 4,960,691, which is hereby incorporated by reference and which relates to devices for conducting specific binding assays utilizing the sequential chromatographic transport of analyte and reagent materials. Wash and addition steps are inherently carried out and liquid “microcircuitry” can be programmed to carry out a variety of multistep procedures and to avoid the premature mixing of sample materials and reagents. Specifically, the Gordon, et al., sequential transport application relates to devices which comprise a test strip for the detection of an analyte in a sample comprising a length of chromatographic material having the capacity for rapid chromatographic solvent transport of non-immobilized reagents and reactive sample components by means of a selected chromatographic solvent.
Of further interest to the present invention are the disclosures of Piasio, et al., U.S. Pat. No. 4,255,575 and Litman, et al., U.S. Pat. No. 4,391,904. These references relate to specific binding assay methods generally and disclose immobilization of enzyme substrates buffers and cofactors on solid phase matrices.
The present invention relates to devices and methods for determining the presence or amount of an analyte substance in a sample by means or one or more specific binding reactions. The devices include, a chromatographic medium having capillarity and the capacity for chromatographic solvent transport of one or more reactive sample components and non-immobilized reagents including a reaction site at which is present an immobilized reagent capable of binding a member from the group consisting of the analyte substance and a labelled specific binding material. The devices also include a sample application means located adjacent to the chromatographic medium and offset upstream from the reaction site, and a liquid absorption means offset downstream from the reaction site. A method for use of the device to determine the presence or amount of an analyte substance in sample includes the steps (a) applying a volume of a sample to be analyzed to the sample application means whereby the sample is transported along the chromatographic medium through the reaction site to the liquid absorption means, (b) contacting the labelled specific binding material to the reaction site, (c) removing unbound sample materials and unbound labelled specific binding materials from the reaction site and (d) determining the presence or amount of labelled specific binding material immobilized at the reaction site as an indication of the presence or amount of the analyte substance in the sample.
The unbound sample materials and unbound labelled specific binding materials may be removed from the reaction site by means of a wash step wherein a wash solution is applied to the reaction site, preferably by application through the sample application means. Alternatively, if the labelled binding material is sufficiently dilute, a wash step is not always necessary.
The present invention provides improved methods and devices for the practice of chromatographic specific binding assay techniques. Devices according to the invention are characterized by a high capture efficiency which is particularly advantageous in the use of the invention for diagnosis of pediatric and geriatric patients where the volume is of sample fluids obtainable from such patients may be limited. This high capture efficiency results from the chromatographic transport of sample and other reactive materials laterally through the reaction site which forces the materials to flow through a length of chromatographic media containing specific binding agents rather than through or around a narrow thickness of impregnated medium.
The devices are suitable for analysis of samples with heavy loads of particulate matter without the necessity of a prefilter. Particulate matter does not interfere with analyte determination at the location of the reaction site, but instead accumulates at the interface of the sample application means and the chromatographic material. Nevertheless, prefilters, and particularly non-removable ones, may be used and fitted into sample application means where samples comprise especially heavy loads of particulate matter, for example, whole blood.
The devices of the present invention comprise a chromatographic medium with a reaction site, a sample application means located adjacent to the medium and offset upstream from the reaction site and a liquid absorption means located downstream from the reaction site. Present at the reaction site is an immobilized reagent capable of binding a member from the group consisting of said substances and a labelled specific binding material. The chromatographic medium and sample application and liquid absorption means are preferably disposed in a holder. Sample materials and reagents are added together or sequentially to the sample application means, which may comprise an area offset from the reaction site, a well, an absorbent pad, or volumetric delivery device in contact with the chromatographic medium. Preferably, the sample application means is a well or absorbent pad, such as may be fashioned from blotter material. The sample materials and reagents are absorbed into the chromatographic medium and are chromatographically transported along the medium and laterally through the reaction site. Analyte substance and reagent materials may be immobilized by a specific binding reaction at the reaction site while non-analyte sample components and non-immobilized reagents are transported through the chromatographic medium to the liquid absorption means located downstream from the reaction site.
Referring to the drawings,
According to one procedure for use of the device (10) to perform sandwich-type assays, a volume of a sample to be tested for the presence of an analyte substance is added to the sample well. The sample material is absorbed into the chromatographic medium (13) where it begins to flow toward the second end (15). The sample material containing the analyte substance, if any, flows through the reaction site (16) at which a reagent is immobilized which is capable of specifically binding with any analyte substance so as to immobilize it at the reaction site (16). Non-analyte sample materials continue to flow through the chromatographic medium (13) toward the second end (15) where they are absorbed by the blotter material (19).
When transport of the sample material from the sample well (18) to the blotter material (19) is complete a labelled reagent material capable of specifically binding with the analyte substance is added to the sample well (18) such that it is absorbed by the chromatographic medium (13) and transported through the reaction site (16) to the second end (15) of the medium where it is absorbed by the blotter material (19). When any of the analyte substance is immobilized at the reaction site (16) the labelled reagent material reacts with the analyte substance and is also immobilized. Where the reagent material is labelled with a radiolabel, a chromophore or a fluorophore the presence of the labelled material and hence the analyte substance may be detected at the reaction site. Where the reagent material is enzyme-labelled, additional reagents such as enzyme substrates, cofactors and dye precursors may be added to the sample well (18) or directly to the reaction site (16) in order to indicate the presence of the analyte substance.
According to two alternative embodiments, the labelled specific binding material may be included or dried in the chromatographic medium, upstream of reaction site or in the absorbent material of the sample application means such that it is reconstituted by addition of the sample.
The device (10) according to
Various other specific binding assays may be carried out on the devices of the present invention. As an example, the chromatographic medium may be impregnated at additional reaction sites with various immobilized specific binding agents. Such additional reaction sites may be used for the detection of additional analyte substances or may be used, as in a comparison-type assay to quantify the amount of analyte substance present in a sample. Additional reaction zones may be used to capture substances that interfere with accurate determination of the analyte.
The chromatographic medium may be impregnated with other reagents and materials including dye compounds, enzyme substrates, coenzymes and cofactors which react with enzyme labels to produce color signals as is well known in the art. According to one aspect of the present invention, where the labelled specific binding agents are enzyme-labelled the enzyme label being characterized in that its presence may be determined by reaction with members of a signal generating substrate/cofactor group, a first member of the signal generating substrate/cofactor group may be immobilized at a reaction site on the chromatographic medium. A second member of the substrate/cofactor group may be added at an appropriate time to activate the signal generating system if an enzyme label is present. By preimpregnating the reaction site with a member of the signal generating substrate/cofactor group, an additional step is avoided and problems relating to the instability or insolubility of substrates, cofactors and dye precursors when stored together are avoided. Moreover, certain members of the signal generating group of compounds may have low chromatographic mobility with the result that pre-impregnation at the reaction site is particularly preferred.
The devices may be housed singly, in pairs, or in multiple configurations. The housing should preferably be watertight to prevent leakage and may be manufactured from a variety of inert materials, with polymer materials being preferred for their ease of fabrication. The sample well should be of sufficient volume to contain any required amount of sample or reagents to be used with the invention. Where the liquid absorption means is enclosed within the housing of the device, it should be provided with sufficient volume that sample, wash, and reagent materials applied to the device during assay procedures may all be absorbed. According to a preferred embodiment of the present invention wherein the chromatographic media is a strip of nitrocellulose material 0.4 cm wide, sample and reagent volumes ranging from 10 μl to 150 μl are suitably accommodated.
The reaction site is located downstream from the sample application means and is visible to view from either side, either being unenclosed or covered with a transparent material. The reaction site is preferably unenclosed, thus facilitating observation of the presence or absence of signals from the site and also allowing the addition of reagents and/or wash solutions to the reaction site.
The liquid absorption means located downstream from the reaction site absorbs sample materials, reagents and wash solutions and thus allows chromatographic transport of sample and other materials from the first end of the chromatographic medium through the reaction site to the second end of the medium. Without such absorption chromatographic transport would cease and the efficiency advantage resulting from the lateral flow of sample through the reaction site would be lost.
The liquid absorption means can include the chromatographic medium itself wherein sample and reagent materials are transported and absorbed by an extended length of the medium. A particularly preferred aspect of the invention is that wherein the liquid absorption means is located adjacent to the chromatographic medium and is offset downstream from the reaction site. Locating the absorption means adjacent to the chromatographic medium provides additional absorption capacity. Offsetting the absorption means downstream from the reaction site ensures that sample materials, and all other materials introduced upstream of the reaction site flow primarily laterally and not vertically through the reaction site.
The absorption means may consist of an extended length of chromatographic medium but preferably consists of a quantity of blotter material. Cellulosic blotter materials derived from wood pulp or cotton are suitable. The blotter material need not have dimensions similar to those of the chromatographic medium and is generally wider and thicker than the chromatographic medium. The blotter need only be adjacent to the chromatographic medium such that fluid from the chromatographic medium can flow into the blotter. A particularly preferred material is James River Type 52 point blotter material (James River Paper Co., Inc., Richmond, Va.). The absorption means preferably must be capable of absorbing the entire volume of sample material and is preferably capable of absorbing the additional reagents and doing so rather rapidly.
Chromatographic media useful with the present invention include those chromatographic substrate materials having capillarity and the capacity for chromatographic solvent transport of non-immobilized reagents and sample components. The chromatographic media used with the invention are preferably in the form of strips. While a wide variety of chromatographic materials such as woven and non-woven fibrous materials used for paper chromatography are suitable for use with the invention, the use of microporous or microgranular thin layer chromatography substrates is particularly preferred as the use of such materials improves the speed and resolution of the assays according to the invention. The materials should preferably be inert and generally not react physically or chemically with any of the sample components, reagents buffers or reaction products. Co-owned and copending U.S. patent application Ser. No. 912,878 filed Sept. 29, 1986 U.S. Pat. No. 4,960,691 and U.S. patent application Ser. No. 072,459 filed July 13, 1987 Pat. No. 5,120,643, the disclosure of which are hereby incorporated by reference, disclose a wide variety of suitable chromatographic substrate materials. Particularly preferred, however, is the use of a microporous nitrocellulose material with a pore size of 5 μm designated Type SMWP (Millipore Corp., Bedford, Massachusetts).
Because the chromatographic media of the device is preferably chemically inert, it may have to be activated at any reaction site where it is desired to immobilize a specific binding reagent against solvent transport. Various methods will be required to render the reagent immobilized according to the particular chemical nature of the reagent. Generally, when the media is nitrocellulose or a mixed nitrocellulose ester, no special chemical linkage is required for the immobilization of reagents. Various techniques may be used for other materials and reagents which include functionalization with materials such as carbonyldiimidazole, glutaraldehyde or succinic acid, or treatment with materials such as cyanogen bromide. Other suitable reactions include treatment with Schiff bases and borohydride for reduction of aldehyde, carbonyl and amino groups. DNA, RNA and certain antigens may be immobilized against solvent transport by baking onto the chromatographic material. Baking may be carried out at temperatures ranging from about 60° C. to about 120° C. for times varying from about five minutes to about 12 hours, but preferably at about 80° C. for about two hours.
Specific binding reagents useful with the present invention would be readily identifiable to one of skill in the art and include those materials which are members of a specific binding pair consisting of a ligand and a receptor. The ligand and receptor are related in that the receptor specifically binds to the ligands, being capable of distinguishing the ligand from other materials having similar characteristics. The methods and devices according to the present invention are particularly useful in the practice of immunological assay techniques where the specific binding reagents are antigens and antibodies including antibody fragments and synthetic antibodies. Specific binding materials such as avidin, biotin, strepatavidin and antibiotin may also be labelled and utilized in specific binding chromatographic assays according to the invention. The methods, kits and devices may also prove useful in the practice of DNA and RNA hybridization assays and other specific binding assays such as those involving receptors for hormones or other biologically active agents.
Blocking agents useful in preparation of devices for the specific binding of the present invention are those agents capable of blocking excess binding sites on the chromatographic media which might hinder chromatographic solvent transport of sample materials or reagents of the invention. In the construction of devices of the present invention, the chromatographic medium is impregnated with the reagent to be immobilized at the location desired. Once the reagent has been immobilized at the desired site, the strip is then preferably processed so as to block excess binding sites for other reagents or sample materials. Particularly suitable is the use of blocking solutions comprising proteins such as casein, gelatin, albumin or total serum. Such proteins are selected to not interfere with or cross-react with reagent materials of the assays. Blocking of the sites may preferably be conducted by dipping the chromatographic substrate materials in a solution of 0.2% casein in physiological saline and air drying the strip materials. Other methods include dipping in solutions of 0.1% gelatin or 0.1% bovine serum albumin followed by air drying of the substrate materials.
According to this example, sandwich-type immunoassay devices for the detection of Hepatitis B surface antigen (HBsAg) were constructed and used. Microporous nitrocellulose material with a thickness of approximately 0.15 mm and a pore size of 5μm (Millipore SMWP) was laminated to Mylar and adhesive (Monokote, Top Flite Models, Inc., Chicago, Ill.) at 60° to 65° C. in a film dryer apparatus. The membrane and backing was cut to strips 0.4 cm wide and 2.5 cm long. Anti-HBsAg antibodies (Abbott Laboratories, North Chicago, Ill.) (0.1-0.2 μl, 1.5 mg/ml) were applied to the reaction sites and incubated under ambient conditions for 15 minutes. Non-specific binding sites on the chromatographic medium were then blocked and cosubstrate bound by incubation for ten minutes at ambient temperature with a solution comprising 0.1% fish gelatin, 1% sucrose and 0.14 mg/ml nitro blue tetrazolium in 10 mM Tris and 150 mM NaCl (pH 7.6). The strips were then dried at 40° C. for about one hour and stored at ambient in the presence of a desiccant. Devices generally similar to the device of
To the sample application well of each test device was added a 30 μl sample of decalcified plasma which had been spiked with varying concentrations of HBsAg. After the sample had soaked into the first end of the nitrocellulose material, and had been transported through the reaction site to the second end of the nitrocellulose material, been absorbed by the blotter material a 15 μl aliquot of biotin labelled Anti-HBsAg antibodies (1 μg/ml) was added to each sample well. After this solution was transported through the device, a 15 μl aliquot of alkaline phosphatase labelled antibiotin (2 μg/ml) (Abbott Laboratories, North Chicago, Ill.) was added to each sample well and reaction sites were twice washed by addition to each sample well of 15 μl of wash solution comprising 1% Triton X 100 Triton X 100® brand of octylphenoxypolyethoxy ethanol nonionic detergent Tris buffered saline solution. A 15 μl aliquot of developing solution comprising 0.5 mg/ml bromochloroindolylphosphate, 0.1 mg/ml MgCl2 and 1% 2-amino-2-methyl propanol (pH 9.8) was then added to each sample well and a color reaction was allowed to develop for five minutes before the reaction was inhibited by addition of 15 μl of a 10 mM ethylene diamine tetraacetic acid (EDTA) solution. Sample solutions containing no HbsAg produced no signal, the reaction site was white. Sample solutions containing as little as 0.1 ng/ml HbsAg produced readily visible blue-gray spots at the reaction site. The total assay time was 25 minutes.
According to this example, sandwich-type immunoassay devices for the detection of HbsAg were constructed and used wherein the labelled specific binding material is labelled with colloidal gold particles according to the method of co-owned and copending U.S. Ser. No. 072,459 U.S. Pat. No. 5,120,643. The device and materials used were identical to that described according to Example 1, with the exception that nitro blue tetrazolium was omitted from the blocking solution.
To the sample well of each device was added a 50 μl sample of recalcified plasma which had been spiked with varying amounts of HBsAg. After the sample had soaked into the first end of the nitrocellulose material, a 50 μl aliquot of anti-HBsAg antibodies labelled with 40 nm colloidal gold particles adsorbed at 5 μg/ml (Abbott Laboratories) was added to each sample well. The total time for the assay was 15 minutes. Sample solutions containing no HBsAg produced no signal over background. Sample solutions as little as 1.0 ng/ml of HBsAg produced visible purple spots at the reaction site. No wash step was required since the antibody gold particles were sufficiently dilute.
Numerous modifications and variations in practice of the invention are expected to occur to those skilled in the art upon consideration of the foregoing descriptions of preferred embodiments thereof. It is well within the skill in the art to practice the present invention according to a wide variety of methods and formats. Consequently, only such limitations should be placed on the invention as appear in the following claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3723064||Jul 26, 1971||Mar 27, 1973||L Liotta||Method and device for determining the concentration of a material in a liquid|
|US3915647||Aug 16, 1974||Oct 28, 1975||Polaroid Corp||Device for determining the concentration of a substance in a fluid|
|US4094647 *||Jul 2, 1976||Jun 13, 1978||Thyroid Diagnostics, Inc.||Test device|
|US4168146||Jan 15, 1976||Sep 18, 1979||Ab Kabi||Immunoassay with test strip having antibodies bound thereto|
|US4189304||Oct 27, 1978||Feb 19, 1980||Miles Laboratories, Inc.||Device and method for detecting myoglobin|
|US4235601 *||Jan 12, 1979||Nov 25, 1980||Thyroid Diagnostics, Inc.||Test device and method for its use|
|US4255575||May 4, 1979||Mar 10, 1981||Richardson-Merrell Inc.||2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives|
|US4271119||Apr 23, 1980||Jun 2, 1981||Eastman Kodak Company||Capillary transport device having connected transport zones|
|US4323536||Feb 6, 1980||Apr 6, 1982||Eastman Kodak Company||Multi-analyte test device|
|US4361537 *||Aug 11, 1980||Nov 30, 1982||Thyroid Diagnostics, Inc.||Test device and method for its use|
|US4366241 *||Aug 7, 1980||Dec 28, 1982||Syva Company||Concentrating zone method in heterogeneous immunoassays|
|US4391904||Apr 17, 1981||Jul 5, 1983||Syva Company||Test strip kits in immunoassays and compositions therein|
|US4623461||May 31, 1985||Nov 18, 1986||Murex Corporation||Transverse flow diagnostic device|
|US4678757||Apr 11, 1985||Jul 7, 1987||Smithkline Diagnostics, Inc.||Device and method for whole blood separation and analysis|
|US4693834||May 5, 1986||Sep 15, 1987||Murex Corporation||Transverse flow diagnostic kit|
|US4740468 *||Feb 14, 1985||Apr 26, 1988||Syntex (U.S.A.) Inc.||Concentrating immunochemical test device and method|
|US4748115 *||Jan 8, 1986||May 31, 1988||Abbott Laboratories||Substrate formulation in 2-amino-2-methyl-1-propanol buffer for alkaline phosphatase assays|
|US4761381||Feb 26, 1987||Aug 2, 1988||Miles Inc.||Volume metering capillary gap device for applying a liquid sample onto a reactive surface|
|US4861711 *||Dec 13, 1985||Aug 29, 1989||Behringwerke Aktiengesellschaft||Sheet-like diagnostic device|
|US4943522 *||Aug 10, 1988||Jul 24, 1990||Quidel||Lateral flow, non-bibulous membrane assay protocols|
|US4956275 *||Apr 14, 1987||Sep 11, 1990||Molecular Devices Corporation||Migratory detection immunoassay|
|US4960691 *||Sep 29, 1986||Oct 2, 1990||Abbott Laboratories||Chromatographic test strip for determining ligands or receptors|
|US4981786 *||Sep 4, 1987||Jan 1, 1991||Syntex (U.S.A.) Inc.||Multiple port assay device|
|US5030558 *||Nov 7, 1986||Jul 9, 1991||Syntex (U.S.A.) Inc.||Qualitative immunochromatographic method and device|
|US5079142 *||Jan 23, 1987||Jan 7, 1992||Synbiotics Corporation||Orthogonal flow immunoassays and devices|
|US5120643 *||Jul 13, 1987||Jun 9, 1992||Abbott Laboratories||Process for immunochromatography with colloidal particles|
|EP0088636A2||Mar 9, 1983||Sep 14, 1983||Bio-Metrics Systems, Inc.||Quantitative analysis apparatus and method|
|EP0168689A2 *||Jun 28, 1985||Jan 22, 1986||Abbott Laboratories||Immunoassay for detection of common determinant antibody to hepatitis B|
|EP0183442A2||Nov 14, 1985||Jun 4, 1986||Syntex (U.S.A.) Inc.||Chromatographic device and method|
|EP0262328A2||Jul 28, 1987||Apr 6, 1988||Abbott Laboratories||Chromatographic test strip for determining ligands and receptors|
|EP0267006A2||Nov 3, 1987||May 11, 1988||Syntex (U.S.A.) Inc.||Qualitative immunochromatographic method and device|
|EP0296724A2||Jun 1, 1988||Dec 28, 1988||Quidel||Assay and apparatus using a lateral flow, non-bibulous membrane|
|EP0322340A2||Dec 14, 1988||Jun 28, 1989||Disease Detection International Inc.,||Bi-directional lateral chromatographic test device|
|WO1988008534A1||Apr 26, 1988||Nov 3, 1988||Unilever Plc||Immunoassays and devices therefor|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8012770||Jul 31, 2009||Sep 6, 2011||Invisible Sentinel, Inc.||Device for detection of antigens and uses thereof|
|US8183059||Aug 30, 2011||May 22, 2012||Invisible Sentinel, Inc.||Device for detection of target molecules and uses thereof|
|US8476082||Apr 12, 2012||Jul 2, 2013||Invisible Sentinel, Inc.||Device for detection of target molecules and uses thereof|
|US8486717||Jan 4, 2012||Jul 16, 2013||Symbolics, Llc||Lateral flow assays using two dimensional features|
|US8697374||Feb 25, 2009||Apr 15, 2014||3M Innovative Properties Company||Antibodies to Clostridium difficile spores and uses thereof|
|US8835184||Sep 15, 2008||Sep 16, 2014||Biosensia Patents Limited||Analysis system|
|US9199232||Apr 6, 2011||Dec 1, 2015||Biosensia Patents Limited||Flow control device for assays|
|US9341624||Jun 28, 2013||May 17, 2016||Invisible Sentinel, Inc.||Device for detection of target molecules and uses thereof|
|US9347938||Mar 7, 2013||May 24, 2016||Invisible Sentinel, Inc.||Methods for detecting multiple analytes with a single signal|
|US9414813||Sep 29, 2014||Aug 16, 2016||Express Diagnostics Int'l, Inc.||Device for assaying analytes in bodily fluids|
|US9462998||Sep 24, 2012||Oct 11, 2016||Express Diagnostics Int'l, Inc.||Device for assaying analytes in bodily fluids|
|US9475049||Jan 27, 2012||Oct 25, 2016||Invisible Sentinel, Inc.||Analyte detection devices, multiplex and tabletop devices for detection of analyte, and uses thereof|
|US9557330||Oct 12, 2010||Jan 31, 2017||Invisible Sentinel, Inc.||Device for detection of analytes and uses thereof|
|US9599615||Sep 12, 2014||Mar 21, 2017||Symbolics, Llc||Lateral flow assays using two dimensional test and control signal readout patterns|
|US9651549||Mar 15, 2013||May 16, 2017||Genisphere, Llc||Lateral flow assays using DNA dendrimers|
|US9739773||Feb 17, 2015||Aug 22, 2017||David Gordon Bermudes||Compositions and methods for determining successful immunization by one or more vaccines|
|US9816984||Apr 28, 2016||Nov 14, 2017||Invisible Sentinel, Inc.||Device for detection of target molecules and uses thereof|
|US9851366||Apr 12, 2013||Dec 26, 2017||Symbolics, Llc||Lateral flow assays using two dimensional features|
|US20110027908 *||Jul 31, 2009||Feb 3, 2011||Invisible Sentinel||Device for detection of antigens and uses thereof|
|US20110171754 *||Sep 15, 2008||Jul 14, 2011||Gareth Redmond||Analysis system|
|EP3187876A1||Jan 17, 2012||Jul 5, 2017||Symbolics, LLC||Lateral flow assays using two dimensional features|
|WO2011044574A1||Oct 12, 2010||Apr 14, 2011||Invisible Sentinel||Device for detection of antigens and uses thereof|
|WO2012099897A1||Jan 17, 2012||Jul 26, 2012||Symbolics, Llc||Lateral flow assays using two dimensional features|
|WO2013132338A2||Mar 5, 2013||Sep 12, 2013||Calpro As||Competitive immunoassay for calprotectin|
|WO2013132347A2||Mar 5, 2013||Sep 12, 2013||Calpro As||Improved elisa immunoassay for calprotectin|
|WO2014012077A1||Jul 12, 2013||Jan 16, 2014||Genisphere, Llc||Lateral flow assays using dna dendrimers|
|WO2014015076A1||Jul 17, 2013||Jan 23, 2014||Symbolics, Llc||Lateral flow assays using two dimensional features|
|WO2015038978A1||Sep 12, 2014||Mar 19, 2015||Symbolics, Llc||Lateral flow assays using two dimensional test and control signal readout patterns|
|WO2016164365A1||Apr 5, 2016||Oct 13, 2016||Bludiagnostics, Inc.||A test device for detecting an analyte in a saliva sample and method of use|
|U.S. Classification||436/161, 435/7.9, 436/810, 422/70, 436/518, 436/530, 436/170, 436/825, 436/169, 435/969, 436/172, 435/810, 435/962, 435/970, 435/7.92, 436/162, 435/808, 436/178, 435/7.95, 422/412|
|International Classification||G01N37/00, G01N33/58, G01N33/558|
|Cooperative Classification||G01N33/558, Y10T436/255|